Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology
Cardiovascular Innovations and Applications · 2026 · 11 (1)
DOI: 10.15212/cvia.2025.0035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Innovations and Applications, 2026. Verfasst von Lutfu Askin und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoprotegerin (OPG), a glycoprotein in the tumor necrosis factor superfamily, regulates bone metabolism by suppressing the formation and activation of osteoclasts. Nonetheless, increasing evidence underscores its physiological importance, particularly in cardiovascular diseases (CVDs). Elevated OPG levels are associated with atherosclerosis, arterial calcification, and heart failure, thus indicating their involvement in cardiac remodeling and vascular pathology. OPG regulates calcification and vascular homeostasis by restricting the transdifferentiation of vascular smooth muscle cells into osteogenic phenotypes. OPG expression is aberrant in illnesses posing cardiovascular risk, such as aortic valve stenosis, chronic renal disease, and diabetes. Beyond structural regulation, OPG interacts with inflammatory and apoptotic mediators, including RANKL and TRAIL, in signaling pathways linking bone metabolism, inflammation, and vascular dysfunction. Myocardial infarction, left ventricular remodeling, and mortality are associated with elevated circulating OPG and altered OPG/TRAIL ratios. This review discusses molecular and clinical insights regarding OPG’s multifaceted role in CVDs, highlighting its potential as a regulator of disease etiology and a predictive biomarker. In cardiovascular medicine, understanding the OPG/RANKL/TRAIL axis has potential to facilitate targeted therapy and risk stratification.
Zitieren
APA
Askin, L., Tanrıverdi, O., Kaya, E., Poyraz, F., & Baris, V. O. (2026). Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology. Cardiovascular Innovations and Applications, 11(1). https://doi.org/10.15212/cvia.2025.0035
Vancouver
Askin L, Tanrıverdi O, Kaya E, Poyraz F, Baris VO. Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology. Cardiovascular Innovations and Applications. 2026;11(1). doi:10.15212/cvia.2025.0035
BibTeX
@article{Askin2026,
author = {Askin, Lutfu and Tanrıverdi, Okan and Kaya, Erdem and Poyraz, Fatih and Baris, Veysel Ozgur},
title = {Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology},
journal = {Cardiovascular Innovations and Applications},
year = {2026},
volume = {11},
number = {1},
doi = {10.15212/cvia.2025.0035}
}
EUVIMED